RXRX

NASDAQ · Biotechnology

Recursion Pharmaceuticals-A

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.05

+0.08 (+2.02%)

As of Sep 23, 1:15 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 62%

Hold 5 38%

Sell 0 0%

Price Target

Analyst Price Target +613.6% upside

Low Target $21.05

Average Target $28.90

High Target $39.88

Current Price $4.05

Current
$4.05

Target
$28.90

$21.05 $28.90 avg $39.88

Scenario Analysis

Bear Case

$21.05

419.8%

Low target

Base Case

$28.90

+613.6%

Avg target

Bull Case

$39.88

+884.7%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$7.18

-43.6% from high

52-Week Low

$2.77

+46.2% from low

50-Day SMA

$4.31

-6.0% vs SMA

200-Day SMA

$4.89

-17.2% vs SMA

RSI (14)

34.7

Neutral

Target vs 52W High

$28.90

+302.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+141.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.8%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.3%